支链氨基酸治疗门脉性脑病的研究。

Infusionstherapie und klinische Ernahrung Pub Date : 1987-10-01

E H Egberts

{"title":"支链氨基酸治疗门脉性脑病的研究。","authors":"E H Egberts","doi":"","DOIUrl":null,"url":null,"abstract":"Published controlled clinical trials with branched chain amino acids (BCAA) in patients with portosystemic encephalopathy (PSE) are described and their results discussed. A positive effect on PSE by BCAA seems probable but without altering mortality rate. Improvement of nutritional state cannot be finally evaluated.","PeriodicalId":75931,"journal":{"name":"Infusionstherapie und klinische Ernahrung","volume":"14 Suppl 5 ","pages":"53-8"},"PeriodicalIF":0.0000,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Therapeutic studies with branched-chain amino acids in portasystemic encephalopathy].\",\"authors\":\"E H Egberts\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Published controlled clinical trials with branched chain amino acids (BCAA) in patients with portosystemic encephalopathy (PSE) are described and their results discussed. A positive effect on PSE by BCAA seems probable but without altering mortality rate. Improvement of nutritional state cannot be finally evaluated.\",\"PeriodicalId\":75931,\"journal\":{\"name\":\"Infusionstherapie und klinische Ernahrung\",\"volume\":\"14 Suppl 5 \",\"pages\":\"53-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1987-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infusionstherapie und klinische Ernahrung\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infusionstherapie und klinische Ernahrung","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

已发表的支链氨基酸(BCAA)在门系统性脑病(PSE)患者中的对照临床试验进行了描述并讨论了他们的结果。BCAA对PSE的积极影响似乎是可能的，但没有改变死亡率。营养状况的改善不能最终评价。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Therapeutic studies with branched-chain amino acids in portasystemic encephalopathy].

Published controlled clinical trials with branched chain amino acids (BCAA) in patients with portosystemic encephalopathy (PSE) are described and their results discussed. A positive effect on PSE by BCAA seems probable but without altering mortality rate. Improvement of nutritional state cannot be finally evaluated.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Infusionstherapie und klinische Ernahrung

自引率

0.00%

发文量